Cargando…

Synergistic effect of STAT3-targeted small interfering RNA and AZD0530 against glioblastoma in vitro and in vivo

The aim of this study was to explore the synergistic effect of signal transducer and activator of transcription 3 (STAT3)-targeted small interfering (si)RNA and AZD0530 against glioblastoma in vitro and in vivo. Glioblastoma cell lines U87 and U251 were divided into four groups and treated with cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qingjun, Wang, Leibo, Li, David, Zhao, Jingxia, Chen, Shen, Li, Jialin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755172/ https://www.ncbi.nlm.nih.gov/pubmed/31485668 http://dx.doi.org/10.3892/mmr.2019.10596

Ejemplares similares

Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer
por: McGivern, Niamh, et al.
Publicado: (2017)

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
por: Kaye, S, et al.
Publicado: (2012)

Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial
por: van Dyck, Christopher H., et al.
Publicado: (2019)

The effect of the dual Src/Abl kinase inhibitor AZD0530 on Philadelphia positive leukaemia cell lines
por: Gwanmesia, Patricia Mambou, et al.
Publicado: (2009)

AZD0530 sensitizes drug‐resistant ALK‐positive lung cancer cells by inhibiting SRC signaling
por: Zhao, Yi, et al.
Publicado: (2017)

MUC21 induces the viability and migration of glioblastoma via the STAT3/AKT pathway
por: Wang, Leibo, et al.
Publicado: (2022)

Exploring the benefits of in-diet versus repeated oral dosing of saracatinib (AZD0530) in chronic studies: insights into pharmacokinetics and animal welfare
por: Vasanthi, Suraj S., et al.
Publicado: (2023)

A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease
por: Nygaard, Haakon B, et al.
Publicado: (2015)

Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung
por: Baird, Kristin, et al.
Publicado: (2020)

Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy
por: Sharma, Shaunik, et al.
Publicado: (2021)

Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
por: Oswald, Ailsa J., et al.
Publicado: (2023)

An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
por: Huang, R Y-J, et al.
Publicado: (2013)

Survivin small interfering RNA suppresses glioblastoma growth by inducing cellular apoptosis☆
por: Liu, Yanbo, et al.
Publicado: (2012)

Tyrosinase Small Interfering RNA Effectively Suppresses Tyrosinase Gene Expression In Vitro and In Vivo
por: Xiu-Hua, Jia, et al.
Publicado: (2010)

Non-Viral Nanoparticle Delivers Small Interfering RNA to Macrophages In Vitro and In Vivo
por: Zhang, Mei, et al.
Publicado: (2015)

Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo
por: Yan, Shuang, et al.
Publicado: (2013)

Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo
por: Li, Xiaohua, et al.
Publicado: (2008)

Inhibition of foot-and-mouth disease virus replication in vitro and in vivo by small interfering RNA
por: Pengyan, Wang, et al.
Publicado: (2008)

Small interfering RNA–mediated allele-selective silencing of von Willebrand factor in vitro and in vivo
por: Jongejan, Yvonne K., et al.
Publicado: (2023)

In Vitro and In Vivo Interactions of TOR Inhibitor AZD8055 and Azoles against Pathogenic Fungi
por: Sun, Yi, et al.
Publicado: (2022)

Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo
por: Yan, Xinrui, et al.
Publicado: (2008)

In vitro inhibition of feline coronavirus replication by small interfering RNAs
por: McDonagh, Phillip, et al.
Publicado: (2011)

Phenotypic Alteration of BMDM In Vitro Using Small Interfering RNA
por: Halimani, Noreen, et al.
Publicado: (2022)

Optimized In Vivo Transfer of Small Interfering RNA Targeting Dermal Tissue Using In Vivo Surface Electroporation
por: Broderick, Kate E, et al.
Publicado: (2012)

Effects of Defective Interfering Viruses on Virus Replication and Pathogenesis In Vitro and In Vivo
por: Roux, Laurent, et al.
Publicado: (1991)

The effects of small interfering RNA–targeting tissue factor on an in vitro model of neovascularization
por: Peng, Wenyan, et al.
Publicado: (2013)

Prevention of Tendon Adhesions by ERK2 Small Interfering RNAs
por: Ruan, Hongjiang, et al.
Publicado: (2013)

Small Interfering RNA against Transcription Factor STAT6 Leads to Increased Cholesterol Synthesis in Lung Cancer Cell Lines
por: Dubey, Richa, et al.
Publicado: (2011)

Small interfering RNAs on top
Publicado: (2004)

Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo
por: Guo, Fengjun, et al.
Publicado: (2021)

Antiviral and protective effect of small interfering RNAs against rift valley fever virus in vitro
por: Ahmed, Engy. M., et al.
Publicado: (2023)

STAT3 Regulates the Type I IFN-Mediated Antiviral Response by Interfering with the Nuclear Entry of STAT1
por: Wang, Huanru, et al.
Publicado: (2019)

Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study
por: Wu, Hao, et al.
Publicado: (2021)

Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy
por: Wang, Nan, et al.
Publicado: (2021)

Phased secondary small interfering RNAs in Panaxnotoginseng
por: Chen, Kun, et al.
Publicado: (2018)

P05.30. Integrating complementary and alternative medicine into mainstream health care: an empirical study of seven health care services in Australia
por: Singer, J, et al.
Publicado: (2012)

Bridging the gap between in vitro and in vivo: Dose and schedule predictions for the ATR inhibitor AZD6738
por: Checkley, Stephen, et al.
Publicado: (2015)

AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
por: Cha, Byung-Hyun, et al.
Publicado: (2021)

In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery
por: Banizs, Anna B, et al.
Publicado: (2014)

Highly efficacious antiviral protection of plants by small interfering RNAs identified in vitro
por: Gago-Zachert, Selma, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fe43qf7ilobnl27ki6u4ftfn59